Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Nutritional Growth Solutions launches new snack bar to grow kids taller

  • In News
  • May 18, 2021
  • Samantha Freidin
Nutritional Growth Solutions launches new snack bar to grow kids taller

Ever noticed how the nutritional supplements that line the aisles of supermarkets and pharmacies are either for adults or children under the age of three?

What about the kids in the middle? Key development continues well past the age of three and optimal nutrition plays a huge role in reaching developmental milestones.

Addressing this long overlooked market in the nutritional supplements space is Nutritional Growth Solutions (ASX: NGS).

The Company focuses on the health and wellbeing of children between the ages of 3 to 12 years old. Until now, there have been no sufficiently studied options designed for healthy, short and lean children that do not meet the criteria for growth hormone therapy. Nutritional Growth Solutions’ proprietary formulations showed significant effect on growth in children after 6 months of use.

Their range of ‘Healthy Height’ shakes are clinically proven to increase growth in children aged between 3 and 9 years old by 13.8%-34% in their annual growth.

In an effort to make supplement consumption easier and give parents more options, the Company is extending their range to include a snack bar. The snack bar will be available from May exclusively online and in-store in North America.

CEO and Managing Director of NGS, Liron Fendell said “We are very excited to be able to offer our clinically proven formulation through the new snack bar product. The snack bar category was worth approximately USD $20 billion in 2018 and is growing at a 6.6% compound annual growth rate. Snack bars generally work as a heavy meal replacement and a quick healthy snack food.”

“There is increasing consumer preference for bars with less sugar and which provide high fibre content, protein, and other nutritional value. The market for clinically proven nutrition products for children is also growing due to increasing education about preventative health measures, paediatric nutrition and its effect on child development and growth.”

The Healthy Height formula is the cumulation of 20 years of research around nutrition and growth in children.

The release of snack bars is the first of several planned expansions to the NGS range which has already successfully entered numerous global markets.

For the quarter ending March 2021 NGS reported record quarterly revenue of USD $180k, which represents a 76% increase on the previous corresponding period.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.